INSPECS Group plc (AIM:SPEC)
London
· Delayed Price · Currency is GBP · Price in GBX 83.00
-0.12 (-0.14%)
Mar 6, 2026, 4:36 PM GMT
INSPECS Group Revenue
INSPECS Group had revenue of 97.62M GBP in the half year ending June 30, 2025, a decrease of -12.21%. This brings the company's revenue in the last twelve months to 195.28M, up 1.34% year-over-year. In the year 2024, INSPECS Group had annual revenue of 198.26M, down -2.48%.
Revenue (ttm)
195.28M
Revenue Growth
+1.34%
P/S Ratio
0.43
Revenue / Employee
118.06K
Employees
1,654
Market Cap
84.39M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.64B |
| GSK plc | 32.67B |
| Haleon | 11.03B |
| Smith & Nephew | 4.58B |
| EKF Diagnostics Holdings | 50.22M |
| Shield Therapeutics | 30.29M |
| 4basebio | 1.78M |
| Venture Life Group | 31.23M |
INSPECS Group News
- 2 months ago - Inspecs Group Plc Notes H2 Equity Partners' Decision On Not To Make Offer - Nasdaq